ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 120,000 Value ($000) $176 Avg Close — Range —
Q2 2025
Shares 11,028,000 Value ($000) $14,325 Avg Close — Range —
Q1 2025
Shares 9,975,000 Value ($000) $11,486 Avg Close — Range —
Q4 2024
Shares 11,353,000 Value ($000) $12,068 Avg Close — Range —
Q3 2024
Shares 14,663,000 Value ($000) $17,141 Avg Close — Range —
Q2 2024
Shares 15,753,000 Value ($000) $16,974 Avg Close — Range —
Q1 2024
Shares 9,970,000 Value ($000) $9,371 Avg Close — Range —
Q4 2023
Shares 9,160,000 Value ($000) $9,011 Avg Close — Range —
Q3 2023
Shares 10,722,000 Value ($000) $9,864 Avg Close — Range —